NCT01665781View on ClinicalTrials.gov

Erythropoietin in the Prevention of Acute Mountain Sickness

PHASE4CompletedINTERVENTIONAL

Enrollment

39

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Acute Mountain Sickness

Interventions

DRUG

Erythropoietin

Trial Locations (1)

138-736

Soon Bae Kim, M.D., Ph.D., Seoul

Sponsors

Collaborators (1)

HK inno.N Corporation

All Listed Sponsors

collaborator

HK inno.N Corporation

INDUSTRY

lead

University of Ulsan

OTHER